Federal Register notice: FDA makes available its listing of Modifications to the List of Recognized Standards, Recognition List Number: 052.
Federal Register notice: FDA makes available a draft guidance entitled Breast Implants Certain Labeling Recommendations to Improve Patient Communicat...
Harvard Medical School researchers say publicly supported research helped at least 25% of all drugs approved by FDA between 2008 and 2017 and could be...
FDA acting commissioner Ned Sharpless reviews agency steps in 2019 to combat the opioid crisis by implementing the SUPPORT Act.
FDA releases a second method for evaluating presence of NDMA in ranitidine drug products.
FDA revises a guidance and withdraws a Compliance Guide to clarify its risk-based approach to regulatory enforcement of homeopathic drug products.
FDA approves an Allergan supplemental BLA for Botox in treating pediatric patients (two to 17 years of age) with lower limb spasticity, excluding spas...
Federal Register notice: FDA sends to OMB an information collection extension for Data to Support Social and Behavioral Research as Used by the Food a...